TherapeuticsMD (TXMD) News Headlines

▮ More

Date

Headline

10/30/2018 1:20:55 AM FDA Nod For TXMD, Genmab's Multiple Myeloma Study Meets Goal, AMED On Watch

10/29/2018 6:02:51 AM TherapeuticsMD Announces FDA Approval Of TX-001HR: BIJUVA Capsules

9/28/2018 5:42:28 AM Biotech Stocks Facing FDA Decision In October

9/20/2018 7:05:09 AM TherapeuticsMD Announces FDA Grants Annovera Marketing Exclusivity As A New Chemical Entity

9/13/2018 7:04:42 AM TherapeuticsMD Reports Commercial Availability Of Imvexxy 4 Mcg

8/10/2018 11:17:06 PM Week Ahead In Pharmaceuticals: 5 Stocks To Watch (REGN, PFE, ALT...)

8/1/2018 9:39:16 PM TherapeuticsMD Announces Pricing Of Public Offering And Registered Direct Offering For Aggregate Proceeds Of $85 Mln

8/1/2018 1:52:05 AM APLS To Report Data In 2H, CUR Abuzz, Shire Discontinues NASH Trial

7/31/2018 4:14:33 PM Knight Therapeutics Receives License To TX-004HR And TX-001HR In Canada And Israel From TherapeuticsMD

7/30/2018 6:18:07 AM TherapeuticsMD Q2 Net Loss $33.2 Mln Or $0.15/Shr Vs Loss $19.7 Mln Or $0.10/Shr Last Year

6/6/2018 7:04:15 AM TherapeuticsMD Announces Multiple Presentations At International Menopause Society’s 16th World Congress

5/31/2018 12:55:51 AM CRSP Falls On Clinical Hold, PFE Gets FDA Nod, ARWR To Report Data In Nov.

5/30/2018 9:39:39 AM TherapeuticsMD Announces FDA Approval Of IMVEXXY Estradiol Vaginal Inserts For Dyspareunia Treatment

5/30/2018 6:45:31 AM FDA Greenlights TXMD's Imvexxy; Stock Up In Early Trade

5/30/2018 6:05:30 AM TherapeuticsMD Announces FDA Approval Of TX-004HR: IMVEXXY

5/27/2018 5:24:39 AM An Ear To The Pharma: 12 Stocks To Watch (AIMT, TXMD, MDGL…)

5/23/2018 11:07:01 PM TXMD Awaits Big Day Next Week, TEVA Faces FDA In Sep., ESPR On Watch

4/27/2018 11:35:58 PM Biotech Stocks Facing FDA Decision In May

4/11/2018 6:02:05 AM TherapeuticsMD Enters Into Label Negotiations For TX-004HR

3/9/2018 2:04:14 AM FDA Panel Backs Xeljanz For UC, ACRX Abuzz, AGLE Awaits Data This Month

Therapeuticsmd (TXMD)